首页> The Journal of Clinical Endocrinology and Metabolism> Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline (vol 93, pg 3671, 2008)

Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline (vol 93, pg 3671, 2008)

导出原文传递

翻译打印收藏纠错

第一作者： Rosenzweig, J. L.

作者： Rosenzweig, J. L. ; Ferrannini, E. ; Grundy, S. M. ; Haffner, S. M. ; Heine, R. J. ; Horton, E. S. ; Kawamori, R.

发布时间 2021-12-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

The Journal of Clinical Endocrinology and Metabolism

2021年106卷7期

E2847-E2847页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览2

The Journal of Clinical Endocrinology and Metabolism

2021年106卷7期

E2847-E2847页

检索历史清除

Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline (vol 93, pg 3671, 2008)

The Journal of Clinical Endocrinology and Metabolism

相似文献

同项目论文

The Journal of Clinical Endocrinology and Metabolism

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline (vol 93, pg 3671, 2008)

The Journal of Clinical Endocrinology and Metabolism

相似文献

同项目论文

The Journal of Clinical Endocrinology and Metabolism

相关期刊

检索历史清除